Calidi Biotherapeutics Inc (CLDI)
0.191
-0.01
(-3.05%)
USD |
NYAM |
May 06, 09:38
Calidi Biotherapeutics Total Liabilities (Quarterly): 18.25M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.25M |
| September 30, 2023 | 19.68M |
| June 30, 2023 | 73.89M |
| Date | Value |
|---|---|
| December 31, 2022 | 53.04M |
| September 30, 2022 | 45.54M |
| December 31, 2021 | 35.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.25M
Minimum
Dec 2023
73.89M
Maximum
Jun 2023
40.90M
Average
40.27M
Median
Total Liabilities (Quarterly) Benchmarks
| Minerva Neurosciences Inc | 85.36M |
| Viking Therapeutics Inc | 33.63M |
| Regenxbio Inc | 262.23M |
| CytomX Therapeutics Inc | 249.24M |
| Janux Therapeutics Inc | 36.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.02M |
| Shareholders Equity (Quarterly) | -8.235M |